Trials / Conditions / Sclerosis, Systemic

Sclerosis, Systemic

8 registered clinical trials studyying Sclerosis, Systemic — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis NCT04356287	Marie Hudson, MD	Phase 1 / Phase 2
Terminated	An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclero NCT05626751	Amgen	Phase 2
Terminated	A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients NCT04781543	Amgen	Phase 2
Completed	Effects of FT011 in Systemic Sclerosis NCT04647890	Certa Therapeutics	Phase 2
Completed	Prevalence of Hyperprolactinemia in Systemic Scleroderma NCT04746313	University Hospital, Lille	—
Unknown	Pragmatic Clinical Trials in Scleroderma NCT03610217	University of West London	N/A
Terminated	Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effec NCT01559129	Celgene	Phase 2
Completed	A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis NCT01532869	Hoffmann-La Roche	Phase 3